ATIP stock $0.675 close on NYSE 17 Feb 2026: 55.56% short-term upside

ATIP stock finished the session at USD 0.675 on the NYSE on 17 Feb 2026 after a thin-volume rebound from the day low of USD 0.625. The session closed with 1,027 shares traded and the stock remains well below its 50-day average of USD 0.89 and 200-day average of USD 1.40. This note frames ATIP ATI Physical Therapy, Inc. stock as an oversold-bounce candidate, weighing fundamentals, liquidity and a short-term model target. Meyka AI provides this concise market-closed review using price, ratios and a forecast scenario for traders watching recovery setups.

Price action for ATIP stock

ATIP (ATI Physical Therapy, Inc.) closed at USD 0.675 on the NYSE, unchanged from the prior close. The intraday range held between USD 0.625 and USD 0.700, with a year low of USD 0.36 and year high of USD 6.49.

Fundamentals: ATIP stock financials

Revenue per share stands at USD 88.75 and EPS is -19.46, producing a negative PE. Enterprise value is USD 730,265,763.00, while market cap is USD 2,977,763.00, reflecting a very small public float and distorted multiples.

Technicals and oversold bounce setup for ATIP stock

Price sits below both the 50-day (USD 0.89) and 200-day (USD 1.40) averages, a standard oversold signal for a bounce trade. Low momentum readings and thin volume create bounce risk, but the 50%+ rebound scenario is plausible on catalyst-driven recovery.

Liquidity, volume and risk for ATIP stock

Average daily volume is 1,660 versus today’s 1,027, leaving liquidity tight and bid/ask spreads wide. One claim: low float and low liquidity can magnify both gains and losses, increasing execution risk for positions larger than a few thousand dollars.

Meyka AI rates ATIP with a score out of 100 and short-term forecast

Meyka AI rates ATIP with a score out of 100: Score: 68.04 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a short-term recovery target of USD 1.05, versus the current price of USD 0.675, implying a 55.56% upside if the bounce holds. Forecasts are model-based projections and not guarantees.

Strategy and outlook for ATIP stock

For oversold-bounce traders, a constructive plan is to scale in under USD 0.70 with strict stops below the year low USD 0.36 and limit position size due to volatility. Sector context: Healthcare and Medical – Care Facilities are trading mixed, so monitor clinical or reimbursement headlines as catalysts.

Final Thoughts

Key takeaways: ATIP ATI Physical Therapy, Inc. (ATIP stock) closed the market on 17 Feb 2026 at USD 0.675 on the NYSE with thin volume and clear oversold signals. Fundamentals show negative EPS (-19.46) and a tiny market cap of USD 2,977,763.00, which increases capital risk and valuation distortions. Our technical read supports a short-term oversold-bounce setup, and Meyka AI’s forecast model projects USD 1.05 as a plausible near-term target, implying 55.56% upside from the current price. Traders should weigh low liquidity (avg vol 1,660) and a history of wide price swings before allocating capital. Remember, forecasts are model-based projections and not guarantees. Use tight risk controls, confirm any bounce with rising volume, and track company-specific news and sector moves for confirmation. Meyka AI is the AI-powered market analysis platform used to generate this scenario and the grade above.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.